Real-life experience with luspatercept in transfusion-dependent β-thalassemia

Ann Hematol. 2023 Oct;102(10):2965-2967. doi: 10.1007/s00277-023-05381-5. Epub 2023 Jul 27.

Daniela Roccotelli¹, Domenica Grande², Gerolamo Cicco², Antonio Palma^{3

4}, Maria C Longo^{3

4}, Francesco Albano², Angelantonio Vitucci^{3

4}, Pellegrino Musto^{2

3

4}

¹ Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), "Aldo Moro" University School of Medicine, Bari, Italy. d.roccotelli@gmail.com.
² Department of Precision and Regenerative Medicine and Ionian Area (DIMEPRE-J), "Aldo Moro" University School of Medicine, Bari, Italy.
³ Hematology and Bone Marrow Transplantation Unit, AOUC Policlinico, Bari, Italy.
⁴ Regional Reference Center for Thalassemias and Hemoglobinopathies (CERIRETE), AOUC Policlinico, Bari, Italy.

No abstract available

Keywords: Hemoglobin; Luspatercept; Serum ferritin; Transfusion burden; β-Thalassemia.

Publication types